GlassScriptPhysician profile
Ray M Wyman
NPI 1316956857
$176,506.96
in general payments reported to CMS, 2019-2025
30 companies · $4,198 in 2025
The $4,198 reported for 2025 was more than what 80% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $67K · 2020: $31K · 2021: $17K · 2022: $25K · 2023: $19K · 2024: $13K · 2025: $4,198.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $21K · Food and Beverage: $9,475 · Travel and Lodging: $3,537 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $2,200 · Grant: $125 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $64.23.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $20,725.00 |
| Food and Beverage | $9,475.17 |
| Travel and Lodging | $3,536.70 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $2,200.00 |
| Grant | $125.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $64.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $72,188.17 | 2019-2025 | Avvigo Guidance System, Emerge Push, Wolverine Coronary Cutting Balloon |
| Abbott Laboratories | $68,163.86 | 2019-2024 | Coroflow, Optis, Navitor |
| Teleflex LLC | $14,669.75 | 2019-2025 | Turnpike, Guideliner, Manta |
| Shockwave Medical, INC | $6,518.00 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abiomed | $6,185.43 | 2019-2024 | Impella |
| Asahi Intecc USA, INC. | $3,915.18 | 2019-2025 | Asahi Interventional Radiology Wires, Asahi Coronary Wires, Asahi Gaia Next |
| Arrow International, INC. | $1,203.19 | 2022-2024 | Guideliner |
| Biotronik INC. | $677.65 | 2019-2024 | |
| Asahi Intecc Co., LTD. | $564.03 | 2019-2025 | |
| Cardiovascular Systems INC. | $279.65 | 2023 | |
| Novo Nordisk INC | $254.34 | 2021-2023 | Ozempic |
| Medtronic, INC. | $248.19 | 2021-2024 | Na, Stealthstation S8 Platform |
| Siemens Medical Solutions USA, INC. | $230.31 | 2021-2022 | |
| Seigla Medical, INC. | $216.22 | 2024 | |
| Novartis Pharmaceuticals Corporation | $213.32 | 2020-2025 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $191.80 | 2022 | |
| Philips North America LLC | $169.48 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $121.10 | 2022-2023 | Camzyos |
| Medtronic Vascular, INC. | $107.30 | 2019-2020 | |
| Bard Peripheral Vascular, INC. | $102.07 | 2024 | Venclose Maven Catheter |
| Janssen Pharmaceuticals, INC | $76.08 | 2019-2020 | |
| Astellas Pharma US INC | $36.95 | 2021 | |
| Kestra Medical Technology Services, INC. | $28.12 | 2024-2025 | Assure Wcd |
| Boehringer Ingelheim Pharmaceuticals, INC. | $27.54 | 2023 | Jardiance |
| Orthofix Medical, INC. | $25.11 | 2022 | |
| Pfizer INC. | $20.57 | 2023 | |
| Actelion Pharmaceuticals US, INC. | $19.83 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $18.99 | 2021 | |
| Reflow Medical INC | $17.52 | 2024 | |
| Becton, Dickinson and Company | $17.21 | 2024 | Lutonix Drug Coated Balloon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$299,994.40 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ray Wyman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.